Member Info for Wiggly

That's an interesting trade...

The buy price rose quickly from 113 area to 115.5 which suggests it was a buy.

Woops - that should read several hundred billion $ market. Possible trillion $ market.

There will be many competitors however AVCT are leading the race (very likely to finish in the top 3) and will have a product that is the BEST POSSIBLE!

We don't need 100% of the market. 5% would transform ACVT.

With that said - With market leading tech and big partners to penetrate the market I expect substantially higher than 5% market share

You wont get any of my shares!

Need to shake it upwards, significantly!

Potential for detecting the detached spike proteins as well as the intact virus particlesIf the test can detect the intact virus particles it means that it can confirm positive or negative pre symptoms. That would be huge for so many right now.. AirlinesRestaurantsConcertsEtc

Time to sit back and enjoy the ride. I have no doubt now that Avacta is the real deal.

Understandable that investors remain cautious, particular after the recent rise. Also, this is AIM and we've most likely all witnessed many disasters however this feels different and I truly believe is the real deal that will have MEGA rewards.

Exciting times.

If lombard are out.... Expect fireworks

BEST POSSIBLE ANTIGEN TEST. Unless our competition can mirror what we have produced Avacta will rule the market. Why would anyone use a sub standard test for such a critical result - if they could use the best possible.

If carlsberg manufactured Antigen test R&D....

Cytiva and Avacta will now work to develop rapid test strips for the detached spike protein and for the intact virus particle

Major news

Adeptrix News almost 2 weeks old...

Quick process was forecasted (stated in rns) and manufacturing0was expected by June...

Development of a BAMS test capable of diagnosing whether a person has the COVID-19 infection at any specific moment is a quick process and the companies are aiming to have a BAMS test ready for clinical validation, regulatory approval and manufacturing in June.

Adeptrix and Avacta are already in discussion with large-scale manufacturing partners to rapidly deploy this new high throughput test.

Odds on I think.

Suspect we will receive multiple updates next week commencing from 7am tomorrow.

I think quite likely tomorrow / next week the names of the additional partners and also likely to have an update on progress with Cytiva and also Adeptrix.

UK gov under huge pressure to ramp up testing. Currently at 100k capacity and striving to reach 200k (per day) capacity.

How will the tie up with Adeptrix improve UK capacity? How many tests per day increase do we expect?

While I believe the Cytiva LFT will 100% come in to play during summer, the Adeptrix testing should be live within days?

Rapid approval by fda bodes well for Avacta and cytia!

Having listened to the CEO during the webcast I really don't think there is any significant technical risk. He said something along the lines of we should feel very confident as it's already been proven in our lab.

It would appear that technical risk E.G. the risk that the LFT would fail is minimal. The ceo has described fda and ce approval as a process rather than evaluation with associated risk. He has stated clearly that the tech works!

Capital risk? The strategy does not require Avacta to raise any capital to bring the tech to market.

Risk from competition? There does not appear to be anything that is ready to go. In addition, the market size will accommodate multiple suppliers. The ceo talks of the need to partner with more than just cytiva as cytiva won't have capacity alone to meet expected demand....

Risk that cv will blow over in the near term? Highly unlikely..

What other risks are there out there that would prevent sales in the 100s millions to billions?

Mid summer is typically known as June 24th.

By this date Avacta hope to be generating 100s million (potentially) in monthly revenues...

In the run up to this date expect news on testing approval (ceo states clearly during the webcast that technical risk has already been overcome) new partnerships, orders placed etc

Mid summer.

Could AVCT have raised the funds to ensure that they would fight off any hostile T/O ?

How much of the stock did they control pre placing?

And it looks to be testing highs again!

Interesting that Avacta have stated they wish to work with multiple parties, not just Cytiva. This strategy could force Cytiva to act quickly to secure 100% of the pie (e.g. buy the tech from Avacta)